Study Group: Oncologists (EU)(?)
Council Members in this Study Group: 755
Request a survey with this Study Group
Leading Experts in this Study Group
Medical Oncologist and Researcher
Università di Modena e Reggio Emilia
Federica Bertolini, MD, is a Medical Oncologist and Researcher in the Division of GI Medical Oncology at Policlinico di Modena at the University Of Modena and Reggio Emilia. Dr. Bertolini has expertise in treatment of all gastro-intestinal tumors such as colorectal cancer or pancreatic cancer and is...
Director of Medical Oncology
Hospital Clinic Barcelona
Pedro Gascon, MD, PhD, is the Director of Medical Oncology and Scientific Coordinator of the Hematology-Oncology Department at Hospital Clinic Barcelona, Spain. Dr. Gascon is board certified in Internal Medicine, Hematology, and Medical Oncology, and his main clinical interests include colorectal cancer,...
Professor
Christian-Albrechts-Universitat zu Kiel
Stefan Schreiber, MD, is Professor of Medicine and Gastroenterology at the Christian-Albrechts-University in Germany. Dr. Schreiber is responsible for designing, organizing, and conducting phase IB-III clinical trials of novel drugs for inflammatory bowel disease and the functional disorders of the...
Related Study Groups
| Study Group Name | Members |
|---|---|
| Oncologists (Germany, France, Italy) | 344 |
| Hematologists (EU) | 352 |
| Oncologists in Germany | 158 |
| Oncologists in the U.K. | 140 |
| Physicians (Germany) | 1146 |
| Oncologists who Treat Leukemia (EU) | 140 |
| Physicians who Treat CML (EU) | 135 |
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
Hepcidine is a key regulator of iron balence. Despite the availability of some iron makers (ferritin, sideremia and transferrin), hepcidine dosage can aid in the interpretation of complex clinical cases. However, its use could be limited to very particular clinical cases.
Lenalidomide is recently proving that its potential is not limited to myeloma, but can be used also in other B-cell malignancy settings such as lymphoma and CLL. CLL, in particular, needs light and yet efficacious treatments, particularly in the setting of pretreated (at times heavily) patients.
The FLEX trial, a randomized phase 3 study comparing cisplatin-vinorelbine versus the same regimen plus cetuximab, recently showed that the addition of the monoclonal antibody to chemotherapy significantly prolong survival in chemonaive NSCLC. Several aspects could limit the wide use...
Biological efficacy has been shown for a number of cancer vaccines. Clinical efficacy has been shown in few of them. Clinical benefit just in one: idiotype vaccine for B-cell lymphoma. TroVax still has to clear the last hurdle, and likely also the second one.
RSV infection is very difficult to confirm. In my hospital we use molecular determination of RSV genome from nasal secretions. This approach is expensive, time consuming and it does not offer a quick diagnosis. We treat mainly onco-hematological patients, who are at high risk of RSV infection. In the...
Most Common Company Types:
- Academic Medical Center/Hospital or Clinic
- Non-Academic Community Hospital or Clinic
- Government/Military Hospital or Clinic
- Academic Institution*
Most Common Job Types:
- Physician - Attending Physician
- Physician - Division Head
- Physician - Director
- Physician - Department Chair
- Director
- Professor
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms